Summit Therapeutics Inc

Summit is a Massachusetts-based biopharmaceutical company that develops and commercializes antibiotic therapies for the treatment of multidrug-resistant infections.

Business Model:

Revenue: $2M

Employees: 51-200

Detailed Summit Therapeutics Inc Information

Geographic Data

Summit Therapeutics Inc headquarters map

Address: One Broadway,

City: Cambridge

State: MA

Zip: 02142

Country: US

Financial Info

Stage:

grant

Raised Last:

$4M

Raised Total:

$256M

Metrics

1,411,505Website Global Rank

19,267Website Monthly Traffic

Twitter Followers

Description

Summit is a Massachusetts-based biopharmaceutical company that develops and commercializes antibiotic therapies for the treatment of multidrug-resistant infections.

Contact Phone:

Contact Email:

Summit Therapeutics Inc went public on 10/14/2004 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
10/14/2004

IPO Valuation:
$76M

Ticker Symbol:
SMMT

Amount Raised:
$27M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
5/2021 Post-IPO Equity 2 $75M Maky Zanganeh
Robert W. Duggan
Maky Zanganeh
Robert W. Duggan
1/2020 Post-IPO Equity 1 $8.8M Biomedical Advanced Research and Development Authority (BARDA)
Biomedical Advanced Research and Development Authority (BARDA)
Biomedical Advanced Research and Development Authority (BARDA)
Biomedical Advanced Research and Development Authority (BARDA)
8/2018 Post-IPO Equity 1 $2M Biomedical Advanced Research and Development Authority (BARDA)
Biomedical Advanced Research and Development Authority (BARDA)
Biomedical Advanced Research and Development Authority (BARDA)
Biomedical Advanced Research and Development Authority (BARDA)
7/2013 Grant 1 $3.6M Biomedical Catalyst Fund
Biomedical Catalyst Fund
10/2012 Grant 1 $6.4M Wellcome Trust
Wellcome Trust
12/2009 Grant 1 $3.6M Wellcome Trust
Wellcome Trust
7/2018 Grant 1 $4.5M CARB-X
CARB-X
CARB-X
CARB-X
5/2021 Grant $0 CARB-X
CARB-X
3/2018 Post-IPO Equity $21.3M
7/2022 Post-IPO Equity $100M
3/2014 Post-IPO Equity $11.6M
11/2020 Private Placement $50M
7/2022 Post-IPO Equity $100M
2/2020 Post-IPO Equity 1 $1M Eurofarma
Eurofarma
Eurofarma
Eurofarma
6/2019 Post-IPO Equity $64M
12/2019 Post-IPO Equity 1 $50M Robert W. Duggan
Robert W. Duggan
Robert W. Duggan
Robert W. Duggan
5/2021 Grant 1 $4.1M CARB-X
CARB-X
Announced Date Name Price
12/2017 Discuva
3/2007 DanioLabs

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research